Endoglin is a transforming growth factor-␤ (TGF-␤) co-receptor expressed mainly on endothelial cells and involved in cardiovascular development, angiogenesis, and vascular remodeling. This is illustrated by the fact that mutations in the endoglin gene give rise to hereditary hemorrhagic telangiectasia type 1, a dominant vascular disease with clinical manifestations that originate by a mechanism of haploinsufficiency. Thus, studies on the regulated expression of endoglin are crucial to devising therapeutic strategies for hereditary hemorrhagic telangiectasia type 1. Endoglin is highly expressed in the neovasculature associated with hypoxia such as ischemic tissues and tumors, but the molecular mechanism of this up-regulation is unknown. Here, we have investigated the possible regulation of endoglin expression by hypoxia. Surface protein, transcript, and promoter activity levels of endoglin were found to be up-regulated by hypoxia, indicating that the regulation takes place at the transcriptional level. A hypoxia-responsive element downstream of the main transcription start site of the endoglin gene was functionally characterized. Whereas hypoxia alone moderately stimulated endoglin transcription, addition of TGF-␤ under hypoxic conditions resulted in transcriptional cooperation between both signaling pathways, leading to marked stimulation of endoglin expression. Because basal endoglin transcription is sustained by Sp1, and TGF-␤ and hypoxia signaling pathways are mediated by Smad proteins and hypoxia-inducible factor-1 (HIF-1), respectively, the involvement of these transcription factors was analyzed. Functional and co-immunoprecipitation experiments demonstrated the existence of a multiprotein complex (Sp1⅐Smad3⅐HIF-1) on the endoglin promoter, mediating the cooperation between the hypoxia and TGF-␤ pathways. Within this multiprotein complex, Smad3 appears to function not only as a coactivator factor, but also as an adaptor between HIF-1 and Sp1. We propose that basal endoglin transcription (highly dependent on Sp1) may switch from a constitutive to an inducible state through Sp1 interaction with HIF-1 and Smad transcription factors, induced by hypoxia and TGF-␤, respectively.
Endoglin is a transforming growth factor-␤ (TGF-␤) co-receptor expressed mainly on endothelial cells and involved in cardiovascular development, angiogenesis, and vascular remodeling. This is illustrated by the fact that mutations in the endoglin gene give rise to hereditary hemorrhagic telangiectasia type 1, a dominant vascular disease with clinical manifestations that originate by a mechanism of haploinsufficiency. Thus, studies on the regulated expression of endoglin are crucial to devising therapeutic strategies for hereditary hemorrhagic telangiectasia type 1. Endoglin is highly expressed in the neovasculature associated with hypoxia such as ischemic tissues and tumors, but the molecular mechanism of this up-regulation is unknown. Here, we have investigated the possible regulation of endoglin expression by hypoxia. Surface protein, transcript, and promoter activity levels of endoglin were found to be up-regulated by hypoxia, indicating that the regulation takes place at the transcriptional level. A hypoxia-responsive element downstream of the main transcription start site of the endoglin gene was functionally characterized. Whereas hypoxia alone moderately stimulated endoglin transcription, addition of TGF-␤ under hypoxic conditions resulted in transcriptional cooperation between both signaling pathways, leading to marked stimulation of endoglin expression. Because basal endoglin transcription is sustained by Sp1, and TGF-␤ and hypoxia signaling pathways are mediated by Smad proteins and hypoxia-inducible factor-1 (HIF-1), respectively, the involvement of these transcription factors was analyzed. Functional and co-immunoprecipitation experiments demonstrated the existence of a multiprotein complex (Sp1⅐Smad3⅐HIF-1) on the endoglin promoter, mediating the cooperation between the hypoxia and TGF-␤ pathways. Within this multiprotein complex, Smad3 appears to function not only as a coactivator factor, but also as an adaptor between HIF-1 and Sp1. We propose that basal endoglin transcription (highly dependent on Sp1) may switch from a constitutive to an inducible state through Sp1 interaction with HIF-1 and Smad transcription factors, induced by hypoxia and TGF-␤, respectively.
Endoglin is a component of the TGF-␤ 1 receptor complex expressed mainly on the surface of endothelial cells (1, 2) and at lower levels by activated monocytes/macrophages (3) as well as by mesenchymal cells, including fibroblasts (4) and vascular smooth muscle cells (5) (6) (7) . Endoglin binds to members of the TGF-␤ superfamily, including TGF-␤1, TGF-␤3, activin A, BMP-2, and BMP-7 (8, 9) , in the presence of the signaling receptors (9, 10) and modulates cellular responses to TGF-␤1 (2, 10, 11) . Members of the TGF-␤ superfamily regulate gene expression through the Smad family of proteins (12) (13) (14) (15) . Thus, Smad2 and Smad3 mediate TGF-␤/activin signals, whereas Smad1, Smad5, and Smad8 mediate the BMP signals. Smad proteins interact with a variety of transcription factors, leading to synergic transactivation or suppression. Transcription factors such as FAST, TFE-3, PEP2/CBF, activating transcription factor-2, OAZ, AP-1, Sp1, and HIF-1 have been reported to cooperate with Smad proteins (12-14, 16, 17) . Also, the closely related transcriptional coactivators CBP and p300 may promote transcription by facilitating the interaction of Smad proteins with the basal transcriptional machinery or by their associated histone acetylase activity, which remodels chromatin structure (13, 14, 16 ).
An important role for endoglin in cardiovascular development and vascular remodeling has been reported by several experimental approaches. Endoglin expression is modulated during heart development (18, 19) , and it is abundant at the endocardial cushion during valve formation and heart septation on mesenchymal cells of the arterioventricular canal (19) . The function of endoglin in vascular morphogenesis has been demonstrated in knockout mice whose embryos die at 10 -11.5 days because of vascular and cardiac abnormalities (20 -22) . Moreover, the gene encoding endoglin is the target for a dominant autosomal hereditary disease known as hereditary hemorrhagic telangiectasia type 1 (HHT1) (23) . HHT1 is a vascular disorder with clinical manifestations of epistaxis; skin and mucosa telangiectasia; and arteriovenous malformations in lung, liver, and brain (24, 25) . Many of the mutations reported to date in the endoglin gene result in truncated mutant proteins that are neither expressed at the cell surface nor secreted. This and the existence of null allele mutations support haploinsufficiency as the underlying mechanism for the clinical manifestations of HHT1 (26 -29) . In this context, understanding the regulation of endoglin gene expression is crucial to approach therapies to correct the disease as well as to understand the role of endoglin in the vascular system. The endoglin gene maps to chromosome 9q34ter (30) and encodes 15 different exons (23) . The promoter region of the endoglin gene lacks TATA and CAAT boxes, but contains GC-rich tracts with consensus motifs for Sp1 binding (31) . In fact, an Sp1 consensus at Ϫ37 is involved in the basal transcription of endoglin and in the stimulation of the endoglin promoter by TGF-␤ (32). This stimulation is mediated by Smad proteins, which synergize with Sp1 by direct physical interaction in the proximal promoter region (32) .
Most higher eukaryotes require oxygen to meet metabolism demands. Low cellular oxygen tension is found under physiological conditions such as high altitude and after physical exercise. In pathological situations, hypoxic conditions are found in ischemia, inflammation, and neoplasia (33) . Hypoxia activates the transcription of genes that mediate adaptive responses of the organisms to counteract the low oxygen levels in such situations (34, 35) . Transcription of hypoxia-regulated genes is activated via HIF-1, a heterodimeric transcriptional complex formed by HIF-1␣ and Arnt (aryl hydrocarbon receptor nuclear translocator; or HIF-1␤) (36) , both of which belong to the basic helix-loop-helix PAS (Per-Arnt-Sim) family. HIF-1 binds to hypoxia-responsive elements (HREs) and activates transcription of a large variety of genes, including vascular endothelial growth factor (VEGF) (37) (38) (39) ; erythropoietin (40) ; inducible nitric-oxide synthase (41) ; and glucose transporter-1, lactate dehydrogenase A, and phosphoglycerate kinase (42) (43) (44) . Angiogenesis, the process that regulates oxygen access to tissues, is tightly regulated by hypoxia. Interestingly, endoglin plays a critical role in angiogenesis (20 -22) and is highly expressed in the neovascularization associated with hypoxia such as tumors, cerebral ischemic stroke, and atherosclerotic tissues (6, 7, (45) (46) (47) (48) (49) (50) (51) .
In this study, we demonstrate that endoglin expression is induced by hypoxia via the HIF-1 complex, which binds a functional consensus HRE in the endoglin promoter. Also, addition of TGF-␤ under hypoxic conditions results in the formation of a transcriptional multicomplex containing Smad3, Sp1, and HIF-1, leading to a cooperative effect of these factors on endoglin transcription.
EXPERIMENTAL PROCEDURES
Cell Culture-All cell lines were cultured in a 5% CO 2 atmosphere at 37°C in medium containing 10% fetal calf serum, 2 mM L-glutamine, and 100 IU/ml penicillin/streptomycin (Invitrogen), unless otherwise indicated. The human microvascular endothelial cell line HMEC-1 was cultured in MCD131 medium containing 10 g/ml epidermal growth factor and 1 g/ml hydrocortisone, as previously described (52) . The human hepatoma Hep3B, the human epithelioid carcinoma HeLa, and the monkey kidney COS cell lines were cultured in Dulbecco's modified Eagle's medium. The human colon adenocarcinoma SW480.7 cell line was cultured in ␣-minimal essential medium (53) . Drosophila Schneider's S-2 cells were cultured in Schneider's medium (32) . Human umbilical vein endothelial cells (HUVEC) were isolated from cannulated vessels incubated in the presence of collagenase (31) . Detached cells were plated on gelatin-coated flasks and grown in medium 199 supplemented with 20% fetal calf serum and 50 g/ml bovine brain extract. Hypoxic exposure was carried out under 1% oxygen, 5% CO 2 , and 94% nitrogen (AL Air Liquide, Spain) for the times indicated (4 -48 h). Unless, otherwise indicated, treatment of cells with human recombinant TGF-␤1 (R&D Systems, Abingdon, United Kingdom) was performed at a concentration of 200 pM in culture medium supplemented with 0.2% fetal calf serum.
Flow Cytometry-Endoglin expression was determined in HMEC-1 and U-937 cells by incubation with mouse monoclonal antibody P4A4 against human endoglin (54) . After washing, cells were subsequently incubated with fluorescein isothiocyanate-labeled rabbit anti-mouse IgG (Dako, Glostrup, Denmark) and washed, and their fluorescence was estimated with a Coulter EPICS-XL flow cytometer using logarithmic amplifiers. Nonspecific mouse immunoglobulins were used as negative controls.
Northern Blot Analysis-Total RNA from HMEC-1 cells was isolated using an RNeasy kit (QIAGEN Inc.). RNA samples (10 g) were denatured, fractionated on formaldehyde-containing 1.1% agarose gels, and blotted onto nitrocellulose. Membranes were hybridized in 50% formamide at 42°C with excess 32 P-labeled probe and washed under stringent conditions (0.2ϫ SSC and 0.5% SDS at 52°C). The probe used was the 2.4-kb EcoRI fragment of human endoglin cDNA (55) labeled with [␣-32 P]dCTP using the Rediprime II kit (Amersham Biosciences). Radiolabeled bands were detected by autoradiography.
Plasmids-The reporter constructs pCD105(Ϫ50/ϩ350), pCD105(Ϫ350/ϩ350), pCD105(Ϫ450/ϩ350), pCD105(Ϫ965/ϩ350), pCD105(Ϫ1950/ϩ350), and pCD105(Ϫ2450/ϩ350) were derived from the human endoglin promoter as described (32) . Briefly, PCR was carried out in the presence of sequence-specific primers surrounded by HindIII/XhoI sites for directional cloning, and the resulting fragments were double-digested with HindIII and XhoI and inserted at the HindIII/XhoI sites of the reporter luciferase vector pXP2. Site-directed mutagenesis of the HRE motif at ϩ338/ϩ344 in the pCD105(Ϫ50/ϩ350) construct was performed using Pfu Turbo DNA polymerase (Stratagene). Amplification was carried out in the presence of the mutated oligonucleotide encompassing ϩ326/ϩ350 of the endoglin sequence (5Ј-GCGCACAGGCCCCCTTTTGGACAGC-3Ј) and its complementary chain, followed by DpnI digestion of the template DNA. As a control for specificity, the TATA-pXP2 reporter vector, containing the minimal TATA box of the prolactin promoter (kindly provided by Dr. Angel Corbí), was used.
Gal4-Sp1 and Gal4-luciferase reporter constructs were used as previously described (56) . The Drosophila expression vector pAC-Sp1, encoding the 778 amino acids of full-length Sp1, was a generous gift from Dr. Robert Tjian (University of California, Berkeley, CA). The expression vectors pcDNA3-HIF-1␣ and pcDNA3-HIF-1␤, encoding the human HIF-1␣ and HIF-1␤ transcription factors, respectively, were kindly provided by Dr. L. E. Huang (Brigham and Women's Hospital, Harvard Medical School, Boston). The expression vectors pCMV5-FLAG-Smad3 and pCMV5-Smad4-HA, encoding FLAG and hemagglutinin epitopetagged human Smad members, respectively, have been previously described (57) .
Transfections-Transfection of S-2, HeLa, and COS cells was carried out using Superfect (QIAGEN Inc.) according to the manufacturer's protocol. SW480.7 cells were transfected by the calcium phosphate/ DNA precipitation method. Cells in 24-well plates were transfected with the appropriate reporter and/or expression vectors at densities of 5 ϫ 10 4 cells/well. When the reporter vector was cotransfected with expression vectors, the amount of DNA in each transfection was normalized using the corresponding empty vector. Luciferase relative units were determined in a TD20/20 luminometer (Promega, Madison, WI) with a sensitivity range of 0.05-10,000. Each transfection experiment was performed at least three times with different DNA preparations. Correction for transfection efficiency was made by cotransfection with the ␤-galactosidase expression vector pCMV-␤-galactosidase, and the corresponding enzymatic activity was determined using the GalactoLight kit (Tropix Inc.). Experimental results obtained with the promoter constructs are expressed either as arbitrary units of luciferase activity or as -fold induction with respect to the corresponding untreated sample.
Electrophoretic Mobility Shift Assay (EMSA)-EMSA experiments were carried out as described (31) . Briefly, 50 ng of double-stranded oligonucleotides were 32 P-labeled by polynucleotide kinase at a specific activity of 10 8 cpm/g. The probe was an oligonucleotide corresponding to fragment ϩ326/ϩ350 of the endoglin gene (or its mutated version as described above). Nuclear extracts from Hep3B cells (10 g), HUVEC (10 g), or in vitro translated (TNT kit, Promega) HIF-1␣ and HIF-1␤ in pcDNA3 were incubated with 2 ng of labeled probe (10 5 cpm). Binding reactions (20 l) were performed with 2 g of poly(dI-dC) in buffer containing 70 mM KCl, 5 mM MgCl 2 , 0.1 mM ZnCl 2 , 0.5 mM dithiothreitol, 0.05% Nonidet P-40, 10% glycerol, and 20 mM HEPES (pH 7.5) on ice for 30 min. When required, samples were supplemented with antihuman HIF-1␣ monoclonal antibody OZ 12ϩ15 (Lab Vision Corp.). Samples were electrophoresed on a 4.5-7.5% polyacrylamide gel in 0.5ϫ Tris borate/EDTA at 175 V for 3 h. For competition experiments, a 100-fold excess of unlabeled oligonucleotides was incubated in the reaction mixture. Competitor oligonucleotides were the wild-type and mutated sequences of the endoglin promoter encompassing ϩ326/ϩ350 and human wild-type sequence Ϫ1006/Ϫ954 of the VEGF promoter, containing a consensus motif for HIF-1 (17, 37).
Immunoprecipitation and Western Blot Analysis-For immunoprecipitation experiments, HeLa cells were transfected with the appropriate expression vectors; and 48 h later, cells were collected by centrifu-gation, lysed, and subjected to immunoprecipitation with anti-human HIF-1␣ monoclonal antibody OZ 12ϩ15 or anti-FLAG antibody (Sigma). For Western blot analysis, cell extracts and immunoprecipitates were subjected to SDS-PAGE under reducing conditions, and proteins were electrophoretically transferred to nitrocellulose membranes (Millipore Corp.). Filters were blocked with phosphate-buffered saline containing 5% nonfat dry milk for 1 h. Specific immunodetection was carried out by incubation with anti-HIF-1␣ (clone 54, BD Biosciences), anti-Sp1, antiSmad3 (Santa Cruz Biotechnology, Santa Cruz, CA), or anti-FLAG antibody, followed by peroxidase-conjugated rabbit anti-mouse Ig at room temperature. The presence of antigens was revealed using a chemiluminescence assay (Supersignal detection kit, Pierce).
RESULTS

Hypoxia Up-regulates Endoglin Expression and
Cooperates with the TGF-␤ Pathway-Endoglin is highly expressed in the neovasculature associated with hypoxia such as tumors and ischemic tissues, but the molecular mechanism of this upregulation is unknown. Because hypoxia regulates expression of genes involved in angiogenesis, i.e. VEGF (37) (38) (39) , and endoglin plays a critical role in angiogenesis, we postulated that endoglin could be regulated by hypoxia. To test this hypothesis, human endothelial (HMEC-1) and monocytic (U-937) cell lines, both expressing endoglin (2, 3, 11), were cultured under normoxic or hypoxic conditions (21 and 1% oxygen, respectively). At different times of hypoxic or normoxic culture, endoglin expression was measured by flow cytometry. As shown in Fig.  1A , endoglin expression was significantly increased after 24 or 48 h of hypoxia. At 48 h, the increase in endoglin was moderate in HMEC-1 cells (ϳ1.5-fold), whereas U-937 cells were highly stimulated (ϳ9-fold). Overall, endoglin induction values with respect to base-line levels were much higher in monocytic cells than in endothelial cells. This is probably because of the high basal levels of endoglin in cultured endothelial cells (58) , whereas basal endoglin expression in monocytic cells is lower (11) .
Because TGF-␤ increases endoglin expression (11, 31, 32) , we studied whether hypoxia would collaborate with TGF-␤ in the modulation of endoglin surface expression. Thus, HMEC-1 and U-937 cell lines were cultured under normoxic or hypoxic conditions and treated or not with TGF-␤ for 24 h (Fig. 1B) . Hypoxic endothelial and monocytic cells showed increased levels of endoglin (1.2-and 8.7-fold, respectively), whereas treatment with TGF-␤ alone yielded higher increases (1.8-and 12-fold, respectively). However, the highest levels of endoglin expression were obtained in the presence of both stimuli, TGF-␤ and hypoxia (3-fold in endothelial cells and 43-fold in monocytic cells), suggesting cooperation between the two signaling pathways.
Cooperation between TGF-␤ and Hypoxia upon Endoglin Expression Is at the Transcriptional Level-To investigate whether hypoxic and TGF-␤ stimuli also affected the endoglin transcript levels, Northern blot analysis was carried out. Total RNA was extracted from human endothelial cells subjected for 24 h to either normoxic or hypoxic conditions in the presence or absence of TGF-␤. As shown in Fig. 2A , hypoxia was able to induce a significant increase in endoglin mRNA levels (ϳ2-fold), whereas in the presence of TGF-␤, the increase in endoglin RNA levels was even higher (3.4-fold). Furthermore, when endothelial cells were simultaneously treated with TGF-␤ and hypoxia, endoglin transcript levels were markedly increased (8.7-fold) over the levels of the individual treatments, supporting the existence of cooperation between both stimuli.
Next, we analyzed the activity of the endoglin promoter in the presence of hypoxia and/or TGF-␤ to determine whether the collaboration of both stimuli took place at the transcriptional level. For this purpose, we used a reporter containing region Ϫ2450/ϩ350 of the endoglin promoter fused to the luciferase gene (31) . This construct was used to transfect HeLa cells, which express endogenous endoglin (data not shown). Fig. 2B shows hypoxia-and TGF-␤-dependent activation of the luciferase activity (1.8-and 2.5-fold, respectively) and a much stronger induction when both stimuli acted together (5.2-fold). These results are in agreement with those obtained by Northern blot analysis ( Fig. 2A ) and flow cytometry ( Fig. 1) and support the existence of cooperation between the hypoxia and TGF-␤ signaling pathways in endoglin transcription.
The HIF-1 Consensus Site at ϩ338/ϩ344 of Endoglin Is Responsible for the Hypoxic Stimulation of the Endoglin Promoter-The TGF-␤-responsive element in the endoglin promoter has been identified within a GC-rich region at Ϫ48/Ϫ36 that contains three consensus Smad-binding elements partially overlapping with an Sp1-binding site (32) . However, to our knowledge, no specific mapping of HREs has been reported within the endoglin promoter. Through binding to HRE motifs, HIF-1 is able to elicit the hypoxic response over a variety of promoters (35, 59, 60) . Full-length endoglin promoter fragment Ϫ2450/ϩ350, responsive to hypoxia (Fig. 2B) , contains several putative HRE sites. To elucidate the existence of a functional HIF-1-binding site in the endoglin gene promoter, HeLa cells were cotransfected with serial deletions of the promoter, and their activity was analyzed in normoxic or hypoxic conditions (Fig. 3) . Endoglin promoter constructs were designed to span from Ϫ2450 to ϩ350, comprising the whole 5Ј-untranslated region (ϩ1/ϩ350) and excluding the ATG translation initiation codon at ϩ351/ϩ353 (31). Under hypoxic conditions, the promoter activity was stimulated in all constructs (from 1.8-to 2.3-fold induction). The induction was preserved in the smallest promoter construct tested (Ϫ50/ϩ350), suggesting that the HRE might be located within this fragment. In fact, fragment Ϫ50/ϩ350 contains a putative HIF-1-binding site located at ϩ338/ϩ344 within the 5Ј-untranslated region of the endoglin promoter (Fig. 4A ). This sequence (ACGTG) matches the bona fide RCGTG consensus sequence (35) , and it is also flanked by a CACAG sequence, known to bind an accessory transcription factor for the hypoxic response, also present in several promoters of hypoxia-regulated genes such as VEGF and erythropoietin (61) . To assess whether this sequence was able to bind HIF-1, EMSA experiments were carried out using, as a probe, an oligonucleotide containing fragment ϩ326/ϩ350 of the endoglin promoter with in vitro transcribed and translated HIF-1␣ and HIF-1␤ (Fig. 4B) . Addition of recombinant HIF-1␣ and HIF-1␤ to the DNA probe yielded a specific complex that was competed out with HRE-containing oligonucleotides and inhibited by the presence of antibodies to HIF-1. Specific complexes between HIF-1 and the DNA probe were also detected using nuclear extracts from Hep3B cells subjected to hypoxia (Fig. 4C) . The specificity of the retarded complex was confirmed by competition experiments with excess unlabeled oligonucleotides. Wild-type endoglin fragment ϩ326/ϩ350, but not endoglin fragment ϩ326/ϩ350 mutated at the HRE sequence (Fig.  4A) , was able to compete the hypoxia-induced retarded complex (Fig. 4C) . In addition, EMSA experiments using HUVEC nuclear extracts were performed (Fig. 4D) . The retarded complex was triggered by hypoxia and could be supershifted by preincubation with antibodies against HIF-1␣ and HIF-1␤, as previously described (17, 37) . The specificity of the complex was ascertained by effective competition with an excess of unlabeled wild-type endoglin sequence and by VEGF sequence Ϫ1006/Ϫ954, containing a functional HRE consensus motif (17) . However, endoglin fragment ϩ326/ϩ350 mutated at the HRE sequence (Fig. 4A) could not compete the hypoxia-induced retarded complex. Altogether, these results point out the ability of HIF-1, either from a recombinant origin or from hypoxic nuclear extracts, to bind the endoglin promoter at ϩ338/ϩ344, downstream of the main transcription start site.
The functionality of the HRE motif within sequence ϩ326/ ϩ350 was studied with a construct in which the HIF-1-binding site was mutated (CACGT to CTTTT) and fused to the luciferase reporter gene. Both mutant and wild-type reporter vectors were transfected into HeLa cells and then tested for their response to hypoxia. Whereas the wild-type construct showed a clear inducibility by hypoxia (ϳ2.5-fold), the mutant construct was unable to show any response under hypoxic conditions (Fig. 4E) . Thus, these data provide further support for the notion that sequence ϩ338/ϩ344 is a structural and functional HIF-1-binding site and that it is likely involved in the hypoxic induction of endoglin.
To assess whether this sequence was responsible for hypoxic induction and subsequent cooperation with the TGF-␤ pathway, the HIF-1 mutant and the wild-type endoglin reporter constructs were transfected into HeLa cells and then tested for hypoxic and TGF-␤ induction (Fig. 4F) . In the HIF-1 mutant,
FIG. 2. Cooperative effect between hypoxia and TGF-␤ on endoglin expression occurs at the transcriptional level.
A, HMEC-1 cells were subjected to normoxia or hypoxia (1% oxygen) and incubated in the presence or absence of TGF-␤ (10 ng/ml) for 24 h. Total RNA was extracted, and endoglin transcripts were detected by Northern blot analysis. The blots were stained by ethidium bromide to visualize the 28 S ribosomal RNA. The intensity of endoglin RNA bands was measured by densitometry, and the results are relative to the corresponding intensity of the 28 S RNA, as shown in the histogram. The numbers on top of the bars indicate the -fold induction of treated cultures relative to the untreated sample, which was given an arbitrary value of 1. The results are representative of two experiments. B, HeLa cells were transiently transfected with the endoglin promoter construct pCD105(Ϫ2450/ϩ350). After 24 h, cells were subjected to either normoxia or hypoxia (1% oxygen) and incubated in the presence or absence of TGF-␤ (10 ng/ml) for an additional 24-h period. The transcriptional activity was determined using the luciferase reporter assay. The numbers on top of the bars indicate the -fold induction of treated cultures relative to the untreated sample, which was given an arbitrary value of 1. The results are representative of four experiments. the hypoxic response was abolished, but TGF-␤ induction was maintained at the same level as in the wild-type promoter. Nevertheless, the cooperative effect between hypoxia and TGF-␤ seen in the wild-type construct was impaired in the HIF-1 mutant. Taken together, these results confirm that sequence ϩ338/ϩ344 contains a functional HRE motif in the endoglin promoter and that there is a functional cooperation between the TGF-␤ and hypoxia pathways in endoglin transcription when both elements, the HRE and Smad-binding element, are intact.
Cooperation between TGF-␤ and Hypoxia Is Mediated by HIF-1, Smad
Proteins, and Sp1-Once involvement of HIF-1 in the hypoxic induction of the endoglin promoter was established, it was of interest to assess whether overexpression of this factor could mimic hypoxia. On the other hand, because Smad3/4 mediates TGF-␤ induction in the endoglin promoter (32), the Ϫ50/ϩ350 construction was used as a reporter to assess whether the existing collaboration between hypoxia and TGF-␤ was reproducible with the corresponding transcription factors mediating these stimuli. For these purposes, HeLa cells were transfected with expression vectors for HIF-1 and Smad3/4. Fig. 5A shows results similar to those shown in Fig.  2B , i.e. Smad3/4 mimicked TGF-␤ induction, and HIF-1 mimicked the hypoxic effect, whereas cotransfection of both transcription factors gave rise to a potent synergistic activation of endoglin promoter activity measured by luciferase.
Once the collaboration between HIF-1 and Smad proteins was demonstrated in the endoglin promoter, we addressed the mechanism by which this collaboration took place. Because there are no putative Smad-binding sites near the HRE (ϩ338/ ϩ344), we considered the Smad-binding site reported previously. As TGF-␤ (via Smad proteins) stimulation of the endoglin promoter is dependent on the Sp1 site (placed at Ϫ37), we postulated that this factor might also be crucial for the cooperation between HIF-1 and Smad proteins. To test this possibility, we performed cotransfections of Sp1, HIF-1␣, and Smad3 in a cell system lacking Sp1, i.e. Drosophila Schneider's S-2 cells (Fig. 5B) . We observed that HIF-1␣ in combination with either Smad3 or Sp1 was able to induce a moderate increase in the promoter activity, similar to the increase observed in the presence of Sp1 and Smad3. Interestingly, the enhanced transactivation values observed in the presence of Sp1 and HIF-1␣ were clearly above the values of the individual treatments, suggesting possible cooperation between Sp1 and HIF-1␣ in the endoglin promoter. Nonetheless, the highest induction of the promoter was obtained when Sp1, HIF-1␣, and Smad3 were simultaneously present. These results suggest that the Sp1 factor, critical for basal endoglin transcription and for its TGF-␤ stimulation, is also important for HIF-1␣/Smad cooperation. However, these experiments were not informative about the role of Smad proteins because S-2 cells do express Drosophila analogs of human Smad proteins (62) . To investigate the possible need for an active Smad pathway, we used SW480 cells, which lack Smad4 and therefore have an impaired TGF-␤ responsiveness. In the absence of Smad signaling, the endoglin promoter activity was unaffected by TGF-␤ treatment (Fig. 5C ), whereas HIF-1 expression could stimulate its activity, but was unable to collaborate with TGF-␤. This effect could be rescued when the Smad4 expression vector was cotransfected. Altogether, the results point out the need for intact Smad signaling to elicit cooperation between the TGF-␤ and hypoxia pathways.
HIF-1␣, Smad3, and Sp1 Form a Multiprotein Complex on the Endoglin
Promoter-Because HIF-1␣, Smad3, and Sp1 are involved in the functional collaboration between TGF-␤ and hypoxia in the endoglin promoter, we investigated the possible physical interaction between these transcription factors. A direct protein interaction between Smad3 and HIF-1, as well as between Smad proteins and Sp1, has been previously reported (17, 32) . Therefore, we hypothesized that Smad3 could be a physical bridge in the interaction between Sp1 and HIF-1. To test this possibility, HeLa cells were transfected with the reporter vector Gal4-luciferase, containing three Gal4-binding sites in tandem and therefore responsive to the Gal4 DNAbinding domain. This reporter was cotransfected with Gal4-Sp1, expressing a fusion protein between the Gal4 binding domain and Sp1; and the Sp1 interaction with HIF-1␣ and Smad3 expression vectors was assessed. The reporter could be FIG. 3 . Mapping an HRE motif on the human endoglin promoter. HeLa cells were transiently transfected with the indicated luciferase reporter constructs, representing serial deletions of the endoglin promoter. After 24 h, cells were subjected to hypoxia (1% oxygen) for an additional period of 24 h, and the transcriptional activity was determined using the luciferase reporter assay. -Fold induction values of treated cultures relative to their corresponding untreated samples are represented. As a negative control, the reporter construct TATA-pXP2, containing a minimal TATA promoter, was included. The dotted line indicates the -fold induction value of 1 as a reference. The results are representative of three experiments.
activated only in the presence of Gal4-Sp1, and both HIF-1␣ and Smad3 were able to increase the luciferase activity when coexpressed with Gal4-Sp1 (Fig. 6A) . The HIF-1␣-dependent induction of the reporter in the presence of Gal4-Sp1 suggests a direct interaction between Sp1 and HIF-1␣, in agreement with the cooperative transactivation observed between both transcription factors in the endoglin promoter (Fig. 5B) . As reported previously (32), Smad3 interacted with Sp1 and accordingly activated the Sp1-dependent induction of the reporter (Fig. 6A) . However, the strongest induction was found when both HIF-1␣ and Smad3 were coexpressed with Gal4-Sp1, indicating that these transcription factors collaborate through direct protein/protein interactions.
The physical interaction between Sp1 and HIF-1 was also demonstrated by direct co-immunoprecipitation experiments with HeLa and COS cells (Fig. 6, B and C) . Endogenous Sp1   FIG. 4 . Identification of a functional HRE sequence in the human endoglin gene. A, shown is a diagram of the endoglin promoter fragment contained within the pCD105(Ϫ50/ϩ350) construct. Consensus sequences for the HRE, Smad-binding elements (SBE), and Sp1 are shown. The putative binding motif for HIF-1 (CCACGTG) is contained within oligonucleotide ϩ326/ϩ350, and the wild-type (WT) and mutated (MT) sequences are shown. Mutated nucleotides (in boldface) were designed to distort the HIF-1 consensus sequence. Luc, luciferase. B, EMSA was carried out using recombinant HIF-1. HIF-1␣ and HIF-1␤ proteins, synthesized in vitro using a TNT kit, were incubated with radiolabeled oligonucleotide ϩ326/ϩ350 used as a probe. The specific complex containing HIF-1 is indicated. Competitions were made with a 100-fold excess of unlabeled oligonucleotides: wild-type oligonucleotide ϩ326/ϩ350 (W); oligonucleotide ϩ326/ϩ350 mutated at the HIF-1 consensus site (M); and human wild-type sequence Ϫ1006/Ϫ954 of the VEGF promoter, containing a consensus motif for HIF-1 (V). The formation of the HIF-1-containing complex was specifically inhibited by anti-HIF-1␣ antibody (␣H). C, EMSA was carried out using nuclear extracts from Hep3B cells. Hep3B cells were subjected to hypoxic treatment (1% oxygen) for 24 h, and ϳ10 g of nuclear extracts were used for binding reactions with radiolabeled oligonucleotide ϩ326/ϩ350 used as a probe. Normoxic extracts (N) with the same amount of protein were used for comparison. The specificity of the binding was tested by competing with an excess (100-fold) of unlabeled wild-type oligonucleotide ϩ326/ϩ35 or oligonucleotide ϩ326/ϩ35 mutated at the HIF-1 consensus site. D, EMSA was carried out using nuclear extracts from HUVEC. HUVEC were subjected to hypoxic treatment (1% oxygen) for 24 h, and ϳ10 g of nuclear extracts were used for binding reactions with radiolabeled oligonucleotide ϩ326/ϩ350 used as a probe. Normoxic extracts with the same amount of protein were used for comparison. The specificity of the binding was tested by competing with an excess of unlabeled oligonucleotides: wild-type oligonucleotide ϩ326/ϩ350; oligonucleotide ϩ326/ϩ350 mutated at the HIF-1 consensus site; and human wild-type sequence Ϫ1006/Ϫ954 of the VEGF promoter, containing a consensus motif for HIF-1. The specific complex containing HIF-1 and the supershifted complex (SS) induced by anti-HIF-1␣ antibody are shown. E, HeLa cells were transiently transfected with the wild-type (WT) luciferase reporter vector pCD105(Ϫ50/ϩ350) or its version mutated (MUT) at the HRE, as shown in A. After 24 h, cells were subjected to normoxia (white bars) or hypoxia (black bars) for an additional period of 24 h. The transcriptional activity was measured using the luciferase reporter assay. The results are representative of three experiments. F, HeLa cells were transiently transfected with the wild-type luciferase reporter vector pCD105(Ϫ50/ϩ350) or its version mutated at the HRE, as shown in A. After 24 h, cells were exposed to normoxia or hypoxia (1% oxygen) and incubated in the presence or absence of TGF-␤1 (10 ng/ml), as indicated. After 48 h, the transcriptional activity was measured using the luciferase reporter assay. The results are representative three experiments.
was specifically co-immunoprecipitated by antibodies to HIF-1␣ from hypoxia-treated HeLa cells, but the amount of Sp1 was significantly enhanced when the cells were simultaneously treated with hypoxia and TGF-␤ (Fig. 6B) . Also, the hypoxic and TGF-␤ effects were mimicked by cotransfection with their corresponding mediators, HIF-1␣ and Smad3, respectively (Fig. 6C) . Thus, endogenous Sp1 could be detected in anti-HIF-1␣ immunoprecipitates upon transfection with HIF-1␣, but the Sp1 signal was further increased when both HIF-1␣ and Smad3 were cotransfected. These experiments not only support the physical interaction between Sp1 and HIF-1␣, but also demonstrate the existence of a multipartite Sp1⅐Smad3⅐ HIF-1 complex. DISCUSSION We have shown here that human endoglin expression is up-regulated by hypoxia. This is fully compatible with the increased expression of endoglin detected in pathological tissues associated with hypoxic conditions (6, 7, (45) (46) (47) (48) (49) (50) (51) . We have also shown that hypoxia and TGF-␤ cooperate to induce expression of human endoglin at the transcriptional level. This is strikingly similar to the cooperative effect shown by these two stimuli on the expression of human VEGF (17) . Both endoglin and VEGF play a crucial role in the angiogenic process. Endoglin gene ablation in mice leads to defects in cardiovascular development and vascular remodeling (20 -22) , and mutations of the human endoglin gene are responsible for the vascular dysplasia known as HHT1 (24, 25) . On the other hand, VEGF promotes the formation of blood vessels by inducing proliferation, migration, elongation, network formation, and branching of endothelial cells (63) (64) (65) . Endoglin and VEGF involvement in the angiogenic process and their regulated expression by hypoxia and TGF-␤ agree with the fact that hypoxia and TGF-␤ are general regulators of angiogenesis (63, 66, 67) . In a physiological context, the effect of hypoxia is accompanied in many cases by an increase in TGF-␤ levels, especially after processes of sustained hypoxia, which result in up-regulation of TGF-␤1 (68), thereby connecting both stimuli in an autocrine loop. Interestingly, the function and expression of endoglin are closely related to the TGF-␤ system. Endoglin has been characterized as a functional component of the TGF-␤ receptor system (8 -11) ; and endoglin transcription is stimulated by TGF-␤, involving the physical interaction between Smad3/4 and Sp1 transcription factors (31, 32) . Both hypoxia and TGF-␤ are operative factors in several physiological processes such as ischemia, pulmonary hypertension, cancer, and trophoblast differentiation (33, 69 -71) . The cooperative effect between both stimuli on endothelial cells could be a highly adaptive response to optimize angiogenesis under special situations. In this regard, endothelial cells are the first barrier of an organism subjected to environmental changes, ischemia, or tissue injury.
Although endoglin expression was found to be up-regulated by hypoxia, this effect was less than that observed in the presence of TGF-␤. TGF-␤ stimulation reached up to 3-3.5-fold under optimal conditions as seen in this and previous work (31, 32) , whereas hypoxia alone increased the activity of the endoglin promoter by ϳ1.5-2-fold. The combined effect of hypoxia and TGF-␤ yielded a total increase in endoglin promoter activity of up to 7-8-fold, the same type of synergy observed for the VEGF promoter (17) . Overall, TGF-␤ stimulation prevailed over hypoxia in the endoglin promoter ( Figs. 1 and 2) , whereas the reverse applies in the case of the VEGF promoter (17) . This differential behavior is likely because of the specific transcriptional context of each gene. In this sense, the hypoxic effect on the endoglin gene is exerted through HIF-1␣, whose binding site has been localized at ϩ338/ϩ344 of the promoter, downstream of the main transcription start and just before the ATG translation initiation codon at ϩ351/ϩ353. This localization is different from that of the HRE motifs reported in the VEGF (37) and erythropoietin (40) gene promoters, which map 900 bp upstream of transcription initiation site and on a 3Ј-enhancer downstream of the polyadenylation site, respectively. It is worth mentioning that in the endoglin, VEGF, and erythropoietin gene promoters, the functional HRE consist of the same 5Ј-(G/C/T)ACGTG-3Ј consensus sequence (Fig. 4) (37, 40) flanked by CACAGG, the so-called HIF-1 ancillary sequences (61) .
As reported for the VEGF gene (17) , the cooperation between hypoxia and TGF-␤ is mediated by a direct physical interaction between Smad3/4 and HIF-1. However, the model supporting the cooperation between both transcription factors in the case of the endoglin promoter should be slightly different from that of VEGF because of the divergence in the arrangement of their respective responsive elements. A TGF-␤-responsive element has been localized at Ϫ47/Ϫ36, upstream of the transcription start site of the endoglin gene promoter. This site involves Smad3/4 interaction with Sp1 (32), whereas HIF-1 binds to a downstream site at ϩ338/ϩ344. The existence of an alternative mechanism explaining hypoxia through an increase in the amount of nuclearized Sp1 (72) was discarded because binding of Sp1 to the endoglin promoter did not increase after hypoxic treatment in EMSA experiments (data not shown). The direct involvement of both Sp1 and Smad as cooperative factors interacting with HIF-1 was tested. Experiments suppressing the Sp1 contribution (in Sp1-deficient S-2 cells) (Fig. 5B) led to a decrease in the cooperative effect, which was reestablished upon transfection of Sp1. Conversely, assays with an impaired Smad pathway (in Smad4-inactive SW480 cells) (Fig. 5C ) led to a disruption of the HIF-1/TGF-␤ cooperative effect. Therefore, we propose that Sp1 and Smad proteins are necessary elements in the cooperation between the hypoxia and TGF-␤ pathways. The HIF-1/Sp1 interaction was evidenced by immunoprecipitation of HIF-1 and endogenous Sp1 in HeLa cells subjected to hypoxia (Fig. 6B) , and the existence of a tripartite complex (Sp1⅐Smad3⅐HIF-1) was demonstrated in the Gal4 system (Fig.  6A) , where the interaction between proteins is independent on the DNA-binding site. To our knowledge, this is the first report that describes a functional and physical interaction between HIF-1 and Sp1. When the three transcription factors (HIF-1, Sp1, and Smad3) were cotransfected in S-2 cells (Fig. 5B) , the cooperative transactivation of the endoglin promoter reached the maximum level. This functional interaction was confirmed by co-immunoprecipitation of Smad3 and Sp1 together with HIF-1 in COS cells transfected with Smad3 and HIF-1 (Fig.  6C) . Accordingly, we hypothesize that the cooperative effect between hypoxia and TGF-␤ in the transcription of endoglin is mediated through a multiprotein complex. In this complex, the transcription factors would be at least Smad3/4, Sp1, and HIF-1␣/␤ bound to their respective consensus DNA elements: the Smad-binding element (Ϫ47/Ϫ36), the Sp1 consensus (Ϫ37/ Ϫ29), and the HRE (ϩ338/ϩ344). Binding of Sp1 seems to be responsible for the basal expression of endoglin, as supported by the dramatic drop in the transcription activity of the endoglin promoter in the absence of Sp1 (32) . This Sp1-dependent activity will be modulated, depending on the stimulus, by other transcription factors such as Smad proteins (TGF-␤) and HIF-1 (hypoxia), which would interact with the basic transcriptional machinery, allowing the switch from constitutive to inducible transcription.
Thus, in a hypoxic environment, HIF-1␣ will be internalized in the nucleus, binding to the HRE at ϩ338/ϩ344 in the endoglin promoter. This binding allows the stimulation of endoglin transcription under hypoxic conditions, and the stimulation is presumably carried out by HIF-1/Sp1 physical interaction. However, the highest effect of hypoxia is reached in collaboration with the TGF-␤/Smad3 pathway. Because the Smad4⅐Smad3 complex can associate with transcriptional coactivators like CBP and p300 (73) , this might allow enhanced endoglin transcription to occur. This is in agreement with the fact that HIF-1 strongly depends on its CBP/p300 recruitment capability to interact with the basal transcriptional machinery (74) . In addition, cooperative interactions between HIF-1, CREB/activating transcription factor-1, and CBP/p300 have been documented, lending support to the conducting role of CBP/p300 in the simultaneous binding of multiple transcription factors and the subsequent activation of transcription in hypoxia-inducible genes (75) . Compatible with this, HIF-1/Sp1 contacts could be an additional way for HIF-1 to connect with the general transcription factors acting on the endoglin promoter. Smad3 could also stabilize HIF-1/Sp1 binding, reinforcing the multiprotein complex, as suggested by the results obtained after TGF-␤ treatment or Smad3 transfection, which consistently allowed a more productive HIF-1␣/Sp1 co-immunoprecipitation. In this hypothetical model, Smad3 would act not only to facilitate   FIG. 6. HIF-1, Sp1 , and Smad3 physically interact in a multiprotein complex. A, to study protein/protein interactions in the one-hybrid Gal4 system, HeLa cells were transiently transfected with the Gal4-luciferase reporter vector and expression vectors coding for HIF-1␣, Smad3, or Gal4-Sp1 as indicated. After 24 h, the luciferase activity was measured. The results are representative of three experiments, with the corresponding S.D. of three internal replicates. B, HeLa cells were subjected to hypoxia or TGF-␤1 treatment, as indicated. Cell lysates were immunoprecipitated (IP) with anti-HIF-1␣ antibody. Immunoprecipitates and total lysates were separated by SDS-PAGE and blotted onto nitrocellulose. The presence of Sp1 and HIF-1␣ was revealed by incubating the filters with anti-Sp1 and anti-HIF-1␣ antibodies, respectively. The results are representative of three experiments. C, COS-7 cells were transfected with expression vectors encoding HIF-1␣ or FLAG-Smad3, as indicated. Cell lysates were immunoprecipitated with anti-HIF-1␣ antibody. Immunoprecipitates were separated by SDS-PAGE and blotted onto nitrocellulose. The presence of Sp1, HIF-1␣, and Smad3 was revealed by incubating the filters with anti-Sp1, anti-HIF-1␣, and anti-FLAG antibodies, respectively. The results are representative of four experiments. recruitment of CBP/p300, but also as a common adaptor for the interactions between different transcription factors.
Although the experiments reported here suggest that the HRE at ϩ338/ϩ344 in the endoglin promoter is functional, it is worth mentioning that the methodological approach involved (Fig. 4) has some limitations. Therefore, the conclusions drawn should be confirmed by addressing the role of the HRE in the endogenous endoglin gene within a more physiological context, a study that is outside the scope of this work. In this sense, the biological importance of an HRE in the VEGF promoter has been substantiated by generating knock-in mice using targeted Cre/loxP recombination (76) . Thus, deletion of this HRE from the VEGF gene leads to chronic vascular insufficiency and motor neuron generation. Similar studies on the HRE of the endoglin gene remain to be carried out. Nevertheless, supporting the possible physiological relevance of the HRE motif in the human endoglin gene is the conservation of the HRE and ancillary sequences in the mouse 2 and rat 3 homologs. Finally, unveiling the mechanisms controlling the expression of endoglin, as in this report, might be relevant to certain pathologies in which endoglin expression is deregulated. Endoglin is the locus mutated in HHT1, a vascular disease with clinical manifestations that are the result of a haploinsufficiency leading to a decrease in the endoglin content of endothelial cells (26 -29) . Therefore, the present study may help in designing new therapeutic strategies to treat HHT1 by increasing expression of the normal endoglin allele. On the other hand, endoglin has been found to be up-regulated in the tumor neovasculature (45) (46) (47) (48) (49) 77) , and several anti-endoglin antibodymediated immunotherapies have been shown to suppress the growth of human tumor xenografts in severe combined immunodeficient (SCID) mice (48, 78, 79) . Thus, the results from the endoglin regulation studies shown here might be useful to optimize the expression and recognition of endoglin as a marker of the tumor vasculature in the anti-angiogenic therapy of cancer.
